Status | Study |
Not yet recruiting |
Study Name: The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research Condition: Acromegaly Date: 2017-05-06 Interventions: Procedure: Transnasal butterfly surgery |
Recruiting |
Study Name: Developing a Simple Recognition System of Acromegaly Condition: Acromegaly Date: 2017-02-01 |
Recruiting |
Study Name: Treatment Patterns and Treatment Outcomes for Acromegaly Condition: Acromegaly Date: 2017-01-30 |
Recruiting |
Study Name: Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects With Acromegaly Condition: Acromegaly Date: 2016-11-10 Interventions: Drug: BIM23B065 Subcutaneous twice a day or three times a day administration of BIM23B065. Dose will be |
Not yet recruiting |
Study Name: Strict IGF-1 Control in Acromegaly Condition: Acromegaly Date: 2016-10-26 Interventions: Drug: Pegvisomant Study medications will be prescribed as per clinical practice with PEGV being added, o |
Recruiting |
Study Name: PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon Condition: Pituitary Tumor Date: 2016-07-27 |
Recruiting |
Study Name: Lanreotide Autogel 120 mg at Extended Dosing Intervals (>4 Weeks) in Acromegalic Subjects Condition: Acromegaly Date: 2016-05-27 |
Completed |
Study Name: Prevalence of Acromegaly in a Diagnostic Consultation for Sleep Apnea Syndrome Condition: Sleep Apnea Syndrome Date: 2016-05-11 Interventions: Other: Diagnosis of acromegaly Biological analysis of IGF-1 |
Terminated |
Study Name: Therapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg Condition: Acromegaly Date: 2016-02-26 |
Recruiting |
Study Name: Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly Condition: Acromegaly Date: 2016-01-28 Interventions: Drug: Octreotide capsules Octr |